| Lead Manager/ | # of | Price Range | Dollar | SCOOP | ||
| New Filings (Proposed Symbol) | Joint-Lead Managers | Shares | Low | High | Volume | Ratings |
| AveXis (AVXS) | Goldman Sachs/ Jefferies | $115.00 | n.a. | |||
| Oncobiologics (ONS) | Jefferies/ Barclays | $115.00 | n.a. | |||
| Senseonics Holdings (SENS) | Leerink Partners/ Canaccord Genuity | $57.00 | n/c | |||
| n.a. (not available) | ||||||
| N/C = No Call – The deal is a public offering currently listed on OTCQB under symbol “SENH.” | ||||||
| Postponed | ||||||
| None | ||||||
| Withdrawn | ||||||
| None | ||||||
| New Terms | ||||||
| Advanced Inhalation Therapies (AITPU) (u) | Joseph Gunnar & Co. | 0.68 | $15.00 | $15.00 | $10.13 | n.a. |
| AmeriQuest (AMQ) | Raymond James/ Stephens | 6.15 | $11.00 | $13.00 | $73.85 | n.a. |
| Elevate Credit (ELVT) | UBS Securities/ Jefferies/ Stifel/ William Blair & Company | 3.60 | $20.00 | $22.00 | $75.60 | 1-Star |
| Monster Digital (MSDI) | Joseph Gunnar/ Axiom Capital Management | 1.00 | $15.00 | $15.00 | $15.00 | n.a. |
| Nordic Realty Trust (NORT) | Wunderlich Securities | 5.00 | $15.00 | $15.00 | $75.00 | n.a. |
| PLx Pharma (PLXP) | Raymond James/ Maxim Group LLC | 3.80 | $17.00 | $19.00 | $68.40 | n.a. |
| n.a. (not available) | ||||||
| IPOs Priced | Lead | Shares | Amount | Offer | Close | % |
| Week of Jan. 11, 2016 | Manager(s) | Offered | Raised | Price | 1/15/16 | Change |
| None | ||||||
